FLNTMEDIUM SIGNALFINANCIAL10-K

FLNT experienced an 18% revenue decline alongside meaningfully reduced R&D spending, though operating cash flow improved substantially from prior year losses.

The revenue contraction paired with significant R&D cuts suggests potential margin preservation efforts, but raises questions about the company's investment in future growth. The material improvement in operating cash flow indicates better working capital management despite lower sales volumes.

Comparing 2026-03-31 vs 2025-03-31View on EDGAR →
FINANCIAL ANALYSIS

FLNT's financial profile shows a company managing through a challenging period, with revenue declining 18% to $208.8M while R&D expenses were cut by over 30% to $11.8M. Operating cash flow improved substantially from negative $14.1M to negative $1.5M, supported by a nearly 40% reduction in accounts receivable. The balance sheet shows mixed signals with cash increasing to $12.9M but stockholders' equity declining to $18.2M, suggesting ongoing profitability challenges despite improved cash generation.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
+89.6%
-$14.1M-$1.5M

Operating cash flow surged 89.6% — exceptional cash generation, highest quality earnings signal.

Accounts Receivable
Balance Sheet
-38.8%
$46.5M$28.5M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Cash & Equivalents
Balance Sheet
+37%
$9.4M$12.9M

Cash position surged 37% — strong cash generation or capital raise providing significant financial cushion.

Interest Expense
P&L
-35.3%
$4.7M$3.1M

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

R&D Expense
P&L
-31.5%
$17.3M$11.8M

R&D spending cut 31.5% — could signal cost discipline or concerning reduction in innovation investment.

Stockholders Equity
Balance Sheet
-27%
$25.0M$18.2M

Equity decreased 27% — buybacks or losses reducing book value, monitor solvency ratios.

Revenue
P&L
-18%
$254.6M$208.8M

Revenue softened 18% — monitor whether this is cyclical or structural.

Operating Income
P&L
+14.1%
-$23.7M-$20.3M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

LANGUAGE CHANGES
NEW — 2026-03-31
PRIOR — 2025-03-31
ADDED
false --12-31 FY 2025 true Oversight of cybersecurity risk is managed through a cross-functional governance structure involving our information technology, compliance, and legal functions.
These teams are responsible for the day-to-day management of our cybersecurity program, including risk assessments, control implementation, and incident response preparedness.
Corporate counsel and external legal advisors work closely with management on data security, privacy, and regulatory compliance matters.
Day-to-day responsibility for cybersecurity operations is delegated to senior information technology leadership, with cross-functional coordination among compliance and legal teams.
Management provides quarterly updates to the Audit Committee of the Board of Directors regarding cybersecurity risks, initiatives, and incidents, if any.
+7 more — sign up free →
REMOVED
See Note 12, Variable Interest Entity, for initial assumptions of the fair value.
For the year ended December 31, 2019, the Company received a cash reimbursement of $640 for tenant improvements made to its New York City corporate headquarters.
As of December 31, 2024 and 2023, there were 768,595 outstanding shares of treasury stock for both periods.
During the year ended December 31, 2024, there was a 3,833 change in the vested not delivered balance due to a net 568 shares that were deferred due to timing of delivery of certain shares, along with 3,265 shares that elected deferred delivery.
As of December 31, 2024 and 2023, there were 286,099 and 289,932 outstanding RSUs that were vested not delivered, respectively.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →